SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $34,338,100 | -56.9% | 1,668,518 | -1.4% | 0.00% | -55.6% |
Q2 2023 | $79,585,770 | +37.9% | 1,692,594 | +23.1% | 0.01% | +28.6% |
Q1 2023 | $57,708,000 | +106996.7% | 1,375,318 | -2.7% | 0.01% | 0.0% |
Q4 2022 | $53,884 | -99.9% | 1,412,831 | -7.6% | 0.01% | -22.2% |
Q3 2022 | $59,864,000 | +19.5% | 1,528,747 | -1.5% | 0.01% | +28.6% |
Q2 2022 | $50,112,000 | -6.2% | 1,551,467 | -3.9% | 0.01% | +16.7% |
Q1 2022 | $53,412,000 | -19.6% | 1,613,650 | +3.3% | 0.01% | -25.0% |
Q4 2021 | $66,433,000 | +28.7% | 1,561,622 | +34.1% | 0.01% | +33.3% |
Q3 2021 | $51,605,000 | -20.4% | 1,164,621 | +2.0% | 0.01% | -25.0% |
Q2 2021 | $64,862,000 | -23.3% | 1,141,726 | +1.1% | 0.01% | -27.3% |
Q1 2021 | $84,529,000 | -35.1% | 1,129,316 | -25.0% | 0.01% | -42.1% |
Q4 2020 | $130,291,000 | +42.1% | 1,506,075 | -2.0% | 0.02% | +26.7% |
Q3 2020 | $91,658,000 | +58.6% | 1,536,076 | +10.5% | 0.02% | +36.4% |
Q2 2020 | $57,809,000 | +42.9% | 1,390,309 | -1.3% | 0.01% | +22.2% |
Q1 2020 | $40,447,000 | -59.6% | 1,408,362 | +1.5% | 0.01% | -52.6% |
Q4 2019 | $100,194,000 | -22.6% | 1,387,944 | +50.5% | 0.02% | -26.9% |
Q3 2019 | $129,399,000 | -21.6% | 922,373 | +0.9% | 0.03% | -18.8% |
Q2 2019 | $164,958,000 | +8.9% | 914,201 | -4.0% | 0.03% | +3.2% |
Q1 2019 | $151,426,000 | +66.1% | 952,068 | +0.1% | 0.03% | +47.6% |
Q4 2018 | $91,149,000 | -31.1% | 951,542 | +1.7% | 0.02% | -16.0% |
Q3 2018 | $132,217,000 | -9.5% | 936,058 | +0.3% | 0.02% | -16.7% |
Q2 2018 | $146,035,000 | +25.6% | 932,958 | +29.3% | 0.03% | +20.0% |
Q1 2018 | $116,242,000 | -10.4% | 721,686 | -8.3% | 0.02% | -7.4% |
Q4 2017 | $129,678,000 | +146.1% | 787,307 | -6.1% | 0.03% | +125.0% |
Q3 2017 | $52,700,000 | -19.2% | 838,094 | +2.4% | 0.01% | -20.0% |
Q2 2017 | $65,199,000 | +10.0% | 818,671 | -1.9% | 0.02% | +7.1% |
Q1 2017 | $59,294,000 | +16.3% | 834,295 | -16.5% | 0.01% | +16.7% |
Q4 2016 | $50,999,000 | -8.2% | 998,787 | -17.2% | 0.01% | -14.3% |
Q3 2016 | $55,562,000 | +71.4% | 1,206,544 | +12.1% | 0.01% | +75.0% |
Q2 2016 | $32,423,000 | -1.4% | 1,076,113 | +4.9% | 0.01% | 0.0% |
Q1 2016 | $32,893,000 | -41.6% | 1,025,990 | +6.2% | 0.01% | -42.9% |
Q4 2015 | $56,341,000 | +48.0% | 966,408 | +7.4% | 0.01% | +40.0% |
Q3 2015 | $38,065,000 | -35.6% | 899,460 | +11.1% | 0.01% | -28.6% |
Q2 2015 | $59,102,000 | +48.0% | 809,638 | +1.9% | 0.01% | +55.6% |
Q1 2015 | $39,923,000 | +512.6% | 794,792 | +346.3% | 0.01% | +800.0% |
Q4 2014 | $6,517,000 | +252.1% | 178,071 | +203.0% | 0.00% | – |
Q3 2014 | $1,851,000 | – | 58,775 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |